FTAAX | HBLRX | FTAAX / HBLRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 14 years | - |
Gain YTD | 6.150 | 7.437 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 1.99B | 12.4B | 16% |
Annual Yield % from dividends | 2.49 | 2.97 | 84% |
Returns for 1 year | 11.46 | 14.78 | 78% |
Returns for 3 years | -1.19 | -2.18 | 55% |
Returns for 5 years | 15.21 | 13.15 | 116% |
Returns for 10 years | 27.80 | 32.75 | 85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EEMRX | 7.89 | -0.03 | -0.38% |
MFS Emerging Markets Equity Research C | |||
SUWZX | 37.46 | -0.51 | -1.34% |
DWS Core Equity R6 | |||
IRGFX | 22.86 | -0.39 | -1.68% |
Delaware Ivy Small Cap Growth R6 | |||
BOPIX | 31.84 | -0.55 | -1.70% |
Sterling Capital Special Opps Inst | |||
RCGHX | 16.39 | -0.38 | -2.27% |
Virtus KAR Health Sciences C |